# World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments

> **NCT04647669** · PHASE3 · UNKNOWN · sponsor: **The University of The West Indies** · enrollment: 100 (estimated)

## Conditions studied

- Covid19

## Interventions

- **DRUG:** Remdesivir
- **DRUG:** Acalabrutinib
- **DRUG:** Interferon beta-1a
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT04647669
- **Lead sponsor:** The University of The West Indies
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-01
- **Primary completion:** 2021-11-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04647669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04647669, "World Health Organization (WHO) COVID-19 Solidarity Trial for COVID-19 Treatments". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04647669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*